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Introduction
The introduction of innovative procedures requires
appropriate evaluation. IDEAL recommendations
propose four stages of evaluation, (Idea-Development-
Evaluation-Assessment-Long-term study). The aim of
this study was to review the introduction of an innova-
tive surgical technique according to this framework.
Methods
Literature searches identified articles published between
2000 and 2012 reporting acellular dermal matrix-
assisted prosthetic breast reconstruction (ADMPBR).
Studies were classified by IDEAL-stage as A)descriptive
(IDEAL-1/2a) reporting the feasibility or development of
ADMPBR or B)comparative (IDEAL-2b/3(RCTs) com-
paring ADMPBR with standard techniques. IDEAL
study designs reported before and after 2008/9 were
examined to explore progression of study design
over time.
Results
Of 236 abstracts, 50 papers reporting data on 3,648
patients were included. 24 (48.0%) were IDEAL-1/2a;25
(50.0%) IDEAL-2b and 1 (2%) IDEAL-3. IDEAL-2b-
studies significantly increased from period-1 (2005-
2008) to period-2 (2009-2012)(n=1 to n=24,p<0.01). The
number of IDEAL-1/2a-studies published annually
remained constant (n=2-4). Almost all IDEAL-1/2a stu-
dies (n=20,87.0%) provided comprehensive descriptions
of surgical technique, but less than half (n=11) reported
patient-selection criteria and only 25% documented
seeking patient consent IDEAL-2b-studies were
significantly larger than IDEAL-1/2a-studies (IDEAL-1/
2a-median= 39, inter-quartile range-20-65 vs.IDEAL-
2b-median=73, inter-quartile range-36-186,p<0.01,
Median-test) and more likely to report combined results
from groups of surgeons (n=10 vs.n=5;p=0.06). Short-
term complication reporting was more comprehensive
in IDEAL-2b-studies but there were no differences in
the reporting of histological or technical details across
groups and IDEAL-1/2a-studies were significantly more
likely to report long-term (p=0.03), patient-reported
(p<0.01) and cosmetic outcomes (p=0.05).
Conclusions
The introduction of ADMPBR does not consider previous
evidence and comparative studies are lacking. Well-
designed and conducted studies are needed to appropri-
ately evaluate novel surgical innovations to establish
standards of care, protect patients and surgeons.
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